Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.
Centogene Regains Compliance With Nasdaq Listing Requirement
In December, the company was notified that its shares had failed to meet the Nasdaq's minimum bid price listing requirement.
Unilabs, Ambry Genetics Partner to Market Research-Use Genomic Testing Services Internationally
The companies aim to offer genetic testing for biopharma and government-sponsored research in Europe, Latin America, and the Middle East.
Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific
LC-SCRUM-Asia, a genomic screening project and database that initially launched in Japan in 2013, is expanding and will cover additional countries in the Asia-Pacific region.